Quick answer: QINV and Enzyme Finance are both on-chain asset management platforms, but they serve very different users. Enzyme is an open infrastructure layer where experienced fund managers deploy custom strategies and manage investor capital directly. QINV is an AI-managed index fund: you deposit capital, and a machine learning system handles allocation, rebalancing, and risk management automatically. The right choice depends on whether you want to build a fund or invest in one.
What is Enzyme Finance?
Enzyme Finance is a decentralized on-chain asset management protocol originally launched as the Melon Protocol in 2016, rebranded in 2020, and currently operating across Ethereum, Polygon, and Arbitrum. The platform allows anyone to create and manage tokenized investment vaults, essentially enabling a "Shopify for crypto funds" model where the protocol supplies the infrastructure and the manager brings the strategy.
Fund managers create a Vault (an on-chain wallet holding assets), issue Shares to investors, and execute investment actions through Enzyme's smart contracts. Every swap, rebalancing action, and fee collection happens transparently on-chain. The native MLN token serves as the protocol's utility token: it pays the 0.25% access fee on every transaction, and collected MLN is burned automatically, creating a deflationary mechanism linked to usage.
According to DeFiLlama data (March 2026), Enzyme Finance holds approximately $85 million in Total Value Locked, with annualized protocol fees of around $63,600. The platform's development is led by Avantgarde Finance, a team with traditional finance roots.
What is QINV?
QINV (qinv.ai) is an AI-managed on-chain index fund built on the Base network (an Ethereum Layer 2). Users connect a Web3 wallet, deposit capital, and receive Portfolio Tokens representing diversified crypto exposure. The AI allocation engine automatically selects assets, weights them by a combination of market fundamentals, on-chain signals, and volatility metrics, and rebalances without any manual input.
QINV operates as a non-custodial vault: the smart contracts hold assets, not the company. This means users maintain self-custody of their exposure while benefiting from professional-grade allocation logic. Base's near-zero gas fees make frequent rebalancing economically viable even for smaller portfolio sizes.
Quick comparison: QINV vs Enzyme Finance
| Dimension | QINV | Enzyme Finance |
|---|---|---|
| Primary user | Passive investors | Active fund managers |
| Strategy | AI-managed index fund | User-defined custom strategy |
| Network | Base (L2) | Ethereum, Polygon, Arbitrum |
| Gas fees | Near-zero (Base) | Moderate to high (Ethereum) |
| Rebalancing | Automatic (AI) | Manual by fund manager |
| Custody | Non-custodial vault | Non-custodial vault |
| Minimum expertise | Web3 wallet + deposit | Fund management knowledge |
| Protocol fee | Index management fee | 0.25% per transaction (MLN) |
| Governance token | None required | MLN required |
| Target scale | Retail to mid-tier | Mid-tier to institutional |
How Enzyme Finance works in practice
Enzyme's architecture separates into two layers:
Fund layer: The fund manager interacts with a Hub (control panel) and a series of Spokes (contract modules) that handle asset storage, fee accounting, and share issuance.
Infrastructure layer: Managed by the Melon Council DAO, this layer connects fund vaults to price feeds, executes MLN fee purchases, and provides adapter contracts for supported DeFi protocols (Uniswap, Aave, Compound, and others).
Step 1: Fund creation
The manager visits the Enzyme dashboard, connects a wallet, and deploys a Vault contract. During setup, they configure the investment strategy (long-only, yield farming, arbitrage), the fee structure (management fee, performance fee), and investor access rules (open or whitelisted).
Step 2: Investor deposits
Investors send capital to the Vault and receive Shares tokens in return, representing a proportional claim on the vault's holdings. All holdings are visible on-chain at any time.
Step 3: Active management
The fund manager executes trades, yield farming strategies, or rebalancing actions through Enzyme's adapter contracts. Every action triggers a 0.25% protocol fee, paid in MLN, which is then burned.
Step 4: Withdrawals
Investors redeem their Shares for underlying assets at any time. The redemption price reflects the current Net Asset Value (NAV) of the vault.
How QINV works in practice
QINV removes the fund manager from the equation entirely.
Step 1: Connect wallet
Users connect a compatible Web3 wallet (MetaMask, Coinbase Wallet, etc.) to the QINV interface at qinv.ai.
Step 2: Deposit and mint
Deposit USDC or ETH. The smart contract mints Portfolio Tokens representing your share of the index fund vault.
Step 3: AI manages allocation
The AI allocation engine continuously monitors on-chain data, adjusts asset weights, and executes rebalancing trades through Base-native liquidity. Users receive diversified crypto exposure without any ongoing action required.
Step 4: Exit at any time
Redeem Portfolio Tokens for underlying assets at the current NAV. No lock-up periods, no withdrawal fees, no approval required.
Fees compared
Fee structures differ fundamentally between the two platforms.
| Fee type | QINV | Enzyme Finance |
|---|---|---|
| Protocol access fee | Included in management | 0.25% per transaction (MLN) |
| Management fee | AI management fee | Set by fund manager (varies) |
| Performance fee | Varies by product | Set by fund manager (0-20%+) |
| Gas fees | Near-zero (Base L2) | Moderate to high (Ethereum mainnet) |
| Governance token required | No | Yes (MLN) |
| Fee transparency | On-chain | On-chain |
Enzyme's total cost depends heavily on the individual fund manager's fee settings. A fund with a 2% annual management fee and a 20% performance fee is not unusual on Enzyme, matching hedge fund structures. QINV's AI management approach keeps the fee structure simpler and more predictable for passive investors.
A key cost difference emerges at the network level: Enzyme's primary deployment on Ethereum mainnet means gas fees can meaningfully impact small-to-mid-size positions, especially during high-congestion periods. On Base, QINV's gas costs are typically fractions of a cent per transaction.
Advantages and risks
QINV advantages
- No active management required. The AI handles every allocation decision, making it suitable for investors without fund management expertise.
- Base network efficiency. Near-zero gas fees make frequent rebalancing economically viable for any position size.
- Simple UX. Connect wallet, deposit, hold. No MLN token required, no strategy configuration, no fund manager vetting.
- Non-custodial. Smart contracts hold assets, not the company. Even if QINV ceased operations, funds remain accessible on-chain.
- Diversification by default. Every deposit immediately provides exposure to an AI-curated basket of assets.
QINV risks
- AI dependency. Allocation decisions are algorithm-driven. Users cannot override individual trades or sector weights.
- Smart contract risk. All DeFi vaults carry the risk of contract bugs or exploits, regardless of audit status.
- Market risk. The index reflects broad crypto market moves; a bear market reduces portfolio value.
- Newer platform. Less historical track record than established protocols.
Enzyme Finance advantages
- Maximum flexibility. Fund managers can implement any on-chain strategy: long-only, market neutral, yield farming, multi-asset arbitrage.
- Institutional tooling. Enzyme.Blue provides white-label vault infrastructure for enterprises and funds requiring compliance features.
- Proven track record. Operational since 2019 with approximately $85M in TVL (DeFiLlama, March 2026).
- Composability. Native adapters for Uniswap, Aave, Compound, Curve, and other major DeFi protocols.
- DAO governance. MLN holders vote on protocol upgrades and fee changes.
Enzyme Finance risks
- Requires active management. Performance depends entirely on the individual fund manager's skill and availability.
- Fund manager selection risk. Choosing the wrong manager can lead to significant losses. Vetting is the investor's responsibility.
- MLN price exposure. Protocol fees are paid in MLN, creating additional token price risk.
- Higher gas costs. Ethereum mainnet fees erode returns on smaller positions.
- Steeper learning curve. Creating a fund requires understanding the Hub-Spokes architecture, fee mechanics, and adapter ecosystem.
Which investor profile suits each platform?
| Investor profile | Best fit |
|---|---|
| Passive investor seeking diversified crypto exposure | QINV |
| Experienced DeFi trader launching their own fund | Enzyme Finance |
| Investor with limited time for active management | QINV |
| Fund manager seeking institutional-grade infrastructure | Enzyme Finance |
| Small-to-mid position, cost-sensitive | QINV (Base fees) |
| Institutional or whale capital, complex strategy | Enzyme Finance |
| User who wants AI to manage allocation | QINV |
| User who wants full control over every trade | Enzyme Finance |
Key insight: the comparison between QINV and Enzyme Finance is not really "which is better" but "who are you?" If you want to run a fund, Enzyme gives you the infrastructure. If you want to be an investor in a managed fund without picking a human manager, QINV's AI model closes that gap.
On-chain transparency: what you can verify
Both platforms are fully transparent on-chain, which is a core advantage over centralized alternatives like crypto exchanges or traditional fund managers.
On Enzyme, every vault's holdings, trades, and fee payments are visible on Etherscan. Investors can audit manager behavior in real time.
On QINV, the smart contract vault and all Portfolio Token movements are visible on BaseScan. The AI's allocation decisions are reflected directly in on-chain holdings, not in off-chain reports.
This on-chain transparency contrasts sharply with the FTX collapse in 2022, where user funds were reported as safe until they were not. Non-custodial, on-chain platforms eliminate the counterparty risk that centralized custody introduces.
The AI management argument
The core philosophical difference between QINV and Enzyme is the role of human judgment. Enzyme assumes that skilled fund managers can outperform algorithmic approaches through active discretion. QINV assumes that consistent, rules-based AI management outperforms human emotion and timing errors over a long horizon.
Research from CFA Institute (2024) consistently shows that fewer than 20% of actively managed funds outperform passive index strategies over a 10-year horizon. In traditional finance, this finding drove the shift from active to passive investment vehicles. QINV applies that same logic to DeFi: remove the human manager, automate the index, reduce the cost.
Enzyme does not compete directly with this model. It is the infrastructure layer that allows any strategy, including AI-managed ones, to be deployed on-chain. A team could theoretically build an QINV-like automated fund using Enzyme's vault infrastructure. But for the end investor, QINV offers that finished product directly.
If you want diversified crypto exposure without the complexity of managing individual assets, QINV offers AI-managed on-chain index fund tokens on Base network. Connect your wallet and get started in minutes.
Frequently asked questions
What is the main difference between QINV and Enzyme Finance?
QINV is a finished product: an AI-managed index fund where users deposit capital and the algorithm handles everything. Enzyme Finance is infrastructure: a protocol where skilled fund managers deploy and run their own custom on-chain strategies. QINV is for investors; Enzyme is for fund managers.
Is Enzyme Finance safe for investors?
Enzyme Finance uses audited smart contracts, and holdings are verifiable on-chain at any time. However, the primary risk for Enzyme investors is fund manager selection: performance depends entirely on the strategy and skill of the manager running the specific vault you invest in. The protocol itself does not manage risk on your behalf.
Do I need to buy MLN tokens to use QINV?
No. QINV does not require any governance or utility token to invest. You connect a wallet, deposit USDC or ETH on Base, and receive Portfolio Tokens. Enzyme Finance, by contrast, requires MLN tokens to pay the 0.25% protocol access fee on each transaction.
Which platform charges lower fees overall?
This depends on the Enzyme vault you choose. Some Enzyme fund managers charge 0% management fees; others charge 2% management plus 20% performance fees, similar to traditional hedge funds. QINV's fee structure is consistent and disclosed upfront. Additionally, QINV's Base network deployment means gas costs are near-zero, while Enzyme on Ethereum mainnet incurs moderate gas expenses.
Can I lose all my money on either platform?
Both platforms carry crypto market risk: a severe bear market will reduce portfolio value. Neither platform is immune to smart contract exploits. Enzyme adds an additional risk layer: fund manager error or malicious behavior (though governance controls limit this). QINV's AI management removes human discretion risk but introduces algorithmic dependency. Neither guarantees capital preservation.
Which platform has more TVL?
As of March 2026, Enzyme Finance holds approximately $85 million in TVL according to DeFiLlama. QINV is a newer platform with a growing TVL as it expands on Base network. TVL reflects the total capital deployed, not necessarily returns or risk-adjusted performance.
This article is for educational purposes only and does not constitute financial or investment advice.
